Novel Therapies for Plaque Psoriasis: Aligning the Patient Perspective with Disease Management
Pricing: Free for Members and Non-Members
This activity is supported by an educational grant from Arcutis Biotherapeutics, Inc.
Course Description
Plaque psoriasis disease severity ranges from mild cutaneous to extensive body surface area and multi-organ involvement, yet individuals with mild disease report a high disease burden and significant impact on physical and mental functioning. Advances in understanding the immune-mediated components of plaque psoriasis are driving targeted treatment approaches, adding to the complexity of formulary decisions and pharmacy benefit design. This session will focus on the impact of plaque psoriasis, defining the value of treatment options from the patient perspective, clinical evidence for novel therapies, and managed care considerations to optimize access to appropriate treatment.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to
- Define plaque psoriasis disease burden and the value of treatment outcomes from the patient perspective.
- Review the evidence supporting novel plaque psoriasis therapies.
- Discuss managed care benefit design challenges and strategies to optimize access to appropriate treatment.
Faculty
Kayla Braestrup, PharmD, BCACP
Clinical Pharmacy Specialist – Dermatology and Gastroenterology
Kaiser Foundation Health Plan of the Northwest
Portland, OR
Leah M. Howard, JD
President & CEO
National Psoriasis Foundation
Alexandria, VA
Lynsey Smith, PharmD, BCACP
Clinical Pharmacy Specialist in Drug Use Management: Dermatology, Gastroenterology, Rheumatology
Kaiser Foundation Health Plan of Colorado
Denver, CO
Moderator
Robert Nordyke, PhD
VP
National Pharmaceutical Council
Washington, DC
Financial Relationship Disclosures
Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
Kayla Braestrup Faculty | Disclosed no relevant financial relationships. |
Leah Howard Faculty | Disclosed no relevant financial relationships. |
Lynsey Smith | Disclosed no relevant financial relationships. |
Casey Koch | Disclosed no relevant financial relationships. |
Jennifer Evans Planner | Disclosed no relevant financial relationships. |
- AMCP Staff have disclosed no relevant financial relationships.
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
Accreditation:
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN:0233-0000-23-014-H03-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: March 22, 2023 • Expiration Date: December 31, 2024
Activity Fee: Free for Members and $30 for Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP 2023. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.25 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 1.25 Certificate of Completion
Price
Required Hardware/software
System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities